María Pilar
Garrido López
Profesor/a Asociado/a en CC. de la Salud
University of Toronto
Toronto, CanadáPublications in collaboration with researchers from University of Toronto (1)
2022
-
Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib: ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2)
Journal of Thoracic Oncology, Vol. 17, Núm. 12, pp. 1404-1414